Return on Tangible Equity (Annual)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Humacyte, Inc. (HUMA) had Return on Tangible Equity of -1313.38% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$2.04M
Net Income	$-40.83M
Cost of Goods Sold	$9.70M
Gross Profit	$-7.66M
Operating Expenses	$110.17M
Operating Income	$-108.14M
Non-Operating Income/Expense	$67.30M
Pre-Tax Income	$-40.83M
Normalized Pre-Tax Income	$-40.83M
Income after Taxes	$-40.83M
Income from Continuous Operations	$-40.83M
Consolidated Net Income/Loss	$-40.83M
Normalized Income after Taxes	$-40.83M
EBIT	$-108.14M
EBITDA	$-100.79M
Weighted-Average Shares Outstanding (Basic)	158.16M
Weighted-Average Shares Outstanding (Diluted)	158.16M
Earnings per Share (EPS) (Basic)	$-0.26
Earnings per Share (EPS) (Diluted)	$-0.26
Balance Sheet Financials
Current Assets	$67.80M
Property, Plant, and Equipment	$18.54M
Long-Term Assets	$48.57M
Total Assets	$116.37M
Current Liabilities	$18.37M
Long-Term Debt	$62.42M
Long-Term Liabilities	$94.89M
Total Liabilities	$113.26M
Common Equity	$3.11M
Tangible Shareholders Equity	$3.11M
Shareholders Equity	$3.11M
Common Shares Outstanding	193.00M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-105.04M
Cash Flow from Investing Activities	$-0.88M
Cash Flow from Financial Activities	$61.49M
Beginning Cash	$95.29M
End Cash	$50.85M
Increase/Decrease in Cash	$-44.44M
Stock-Based Compensation	$9.75M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.69
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.95
Debt to Equity Ratio	20.86
Gross Margin	-376.05%
Operating Margin	-5306.03%
EBIT Margin	-5306.03%
EBITDA Margin	-4945.63%
Pre-Tax Profit Margin	-2003.58%
Profit Margin	-2003.58%
Free Cash Flow	$-105.93M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.02
Inventory Turnover	0.71
Receiveable Turnover	4.62
Days Sales in Receivables	78.98
Return on Equity	-1313.38%
Return on Tangible Equity	-1313.38%
Return on Assets	-35.09%
Return on Investments	-62.31%
Book Value Per Share	$0.02
Free Cash Flow per Share	$-0.67
Operating Cash Flow per Share	$-0.66

Data from Zacks Investment Research, Inc.